Cargando…
Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review
With the progressive lengthening of the average age of the population, especially in some countries such as Italy, vaccination of the elderly is a fixed point on which most of the public health efforts are concentrating as epidemic infectious diseases, especially those of the winter, have a major im...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537287/ https://www.ncbi.nlm.nih.gov/pubmed/37766089 http://dx.doi.org/10.3390/vaccines11091412 |
_version_ | 1785113067212767232 |
---|---|
author | Ciarambino, Tiziana Crispino, Pietro Buono, Pietro Giordano, Vincenzo Trama, Ugo Iodice, Vincenzo Leoncini, Laura Giordano, Mauro |
author_facet | Ciarambino, Tiziana Crispino, Pietro Buono, Pietro Giordano, Vincenzo Trama, Ugo Iodice, Vincenzo Leoncini, Laura Giordano, Mauro |
author_sort | Ciarambino, Tiziana |
collection | PubMed |
description | With the progressive lengthening of the average age of the population, especially in some countries such as Italy, vaccination of the elderly is a fixed point on which most of the public health efforts are concentrating as epidemic infectious diseases, especially those of the winter, have a major impact on the progression of severe disease, hospitalization, and death. The protection of the elderly against acute infectious diseases should not only limit mortality but also have a positive impact on the fragility of these people in terms of less disability and fewer care needs. However, vaccination of the elderly population differs in efficacy and safety compared to that of other population categories since aging and the consequent loss of efficiency of the immune system lead to a reduction in the immunogenicity of vaccines without achieving a lasting antibody coverage. There are various strategies to avoid the failure of immunization by vaccines such as resorting to supplementary doses with adjuvant vaccines, increasing the dosage of the antigen used, or choosing to inoculate the serum relying on various routes of administration of the vaccine. Vaccination in the elderly is also an important factor in light of growing antibiotic resistance because it can indirectly contribute to combating antibiotic resistance, reducing theoretically the use of those agents. Furthermore, vaccination in old age reduces mortality from infectious diseases preventable with vaccines and reduces the same rate of resistance to antibiotics. Given the importance and complexity of the topic, in this review, we will deal with the main aspects of vaccination in the elderly and how it can influence mortality and healthcare costs, especially in those countries where population aging is more evident. Therefore, we conducted a systematic literature search in PubMed to identify all types of studies published up to 31 May 2023 that examined the association between vaccination and the elderly. Data extraction and quality assessment were conducted by two reviewers (PC and TC) who independently extracted the following data and assessed the quality of each study. |
format | Online Article Text |
id | pubmed-10537287 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105372872023-09-29 Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review Ciarambino, Tiziana Crispino, Pietro Buono, Pietro Giordano, Vincenzo Trama, Ugo Iodice, Vincenzo Leoncini, Laura Giordano, Mauro Vaccines (Basel) Review With the progressive lengthening of the average age of the population, especially in some countries such as Italy, vaccination of the elderly is a fixed point on which most of the public health efforts are concentrating as epidemic infectious diseases, especially those of the winter, have a major impact on the progression of severe disease, hospitalization, and death. The protection of the elderly against acute infectious diseases should not only limit mortality but also have a positive impact on the fragility of these people in terms of less disability and fewer care needs. However, vaccination of the elderly population differs in efficacy and safety compared to that of other population categories since aging and the consequent loss of efficiency of the immune system lead to a reduction in the immunogenicity of vaccines without achieving a lasting antibody coverage. There are various strategies to avoid the failure of immunization by vaccines such as resorting to supplementary doses with adjuvant vaccines, increasing the dosage of the antigen used, or choosing to inoculate the serum relying on various routes of administration of the vaccine. Vaccination in the elderly is also an important factor in light of growing antibiotic resistance because it can indirectly contribute to combating antibiotic resistance, reducing theoretically the use of those agents. Furthermore, vaccination in old age reduces mortality from infectious diseases preventable with vaccines and reduces the same rate of resistance to antibiotics. Given the importance and complexity of the topic, in this review, we will deal with the main aspects of vaccination in the elderly and how it can influence mortality and healthcare costs, especially in those countries where population aging is more evident. Therefore, we conducted a systematic literature search in PubMed to identify all types of studies published up to 31 May 2023 that examined the association between vaccination and the elderly. Data extraction and quality assessment were conducted by two reviewers (PC and TC) who independently extracted the following data and assessed the quality of each study. MDPI 2023-08-24 /pmc/articles/PMC10537287/ /pubmed/37766089 http://dx.doi.org/10.3390/vaccines11091412 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ciarambino, Tiziana Crispino, Pietro Buono, Pietro Giordano, Vincenzo Trama, Ugo Iodice, Vincenzo Leoncini, Laura Giordano, Mauro Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review |
title | Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review |
title_full | Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review |
title_fullStr | Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review |
title_full_unstemmed | Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review |
title_short | Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review |
title_sort | efficacy and safety of vaccinations in geriatric patients: a literature review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537287/ https://www.ncbi.nlm.nih.gov/pubmed/37766089 http://dx.doi.org/10.3390/vaccines11091412 |
work_keys_str_mv | AT ciarambinotiziana efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview AT crispinopietro efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview AT buonopietro efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview AT giordanovincenzo efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview AT tramaugo efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview AT iodicevincenzo efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview AT leoncinilaura efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview AT giordanomauro efficacyandsafetyofvaccinationsingeriatricpatientsaliteraturereview |